Scholars Central

ArticlePublished 2012

Estimated rates of treatment failure in first-line antiretroviral treatment in Kinshasa: Case of the ACS AMO-Congo

Authors: KAMANGU NTAMBWE ERICK, KAWILA MAFANDA EUPHRASIE, MUKUMBI HENRI, MVUMBI LELO GEORGES

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: In the Democratic Republic of Congo (DRC), the first line of treatment for HIV adopted since 2008 for the PLHIV is a combination of single-dose Azydothimidine (AZT), Lamivudine (3TC) and Nevirapine (NVP). In 2009, 34 947 PLHIV were on the first line HAART in the DRC, of which 28,918 or 82.75% were adults. Objective: Estimate the rate of treatment failure in first-line antiretroviral therapy in treatment centers in Kinshasa. Method: This study is a cross-sectional study in three outpatient treatment centers of the NGO ACS AMO-Congo in the city of Kinshasa in the Democratic Republic of Congo in January 2009. Any patient on antiretroviral therapy in first intension followed regularly in one of three centers of study for more than six months in January 2009 was considered. Blood sampling was done in a tube with EDTA anticoagulant, from a venous puncture. The numbering of CD4 has been made in the laboratory of ACS / AMO-Congo Kasa Vubu on FACSCountTM and viral load at the National Reference Laboratory AIDS / STI (LNRS) by NucliSens Easy Q - HIV1, Version 1, 2. Data were entered using Excel and SPSS software. The Student test was used for quantitative variables and Chi-square (X2) for categorical variables. The significance (p) was chosen for the probability of p <0.05. Results are expressed as mean ± standard deviation. The tables have been reformatted in Excel. Respect for the individual and the confidentiality of records were found. Result: A total of 102 patients were included in this work with a female predominance (66.7%) and a mean age of 41.4 ± 9.4 years. The mean CD4 count of third control (395.5 ± 145.2 cells / l) were significantly higher than those of CD4 at baseline (252.1 ± 128.7 cells / l). Controls were performed CD4 at 1 month (control 1), 3 months (control 2) and ± 6 months (control 3). The viral load (VL) average of 20,258.3 ± 10,209.0 RNA copies / ml. Eighteen patients (17.6%) had a CD4 count lower than the third control values before treatment, 16 patients (15.7%) had a viral load above 1000 RNA copies / ml and 7 patients (6.9%) evolved at the AIDS stage. Conclusion: The estimated rate of treatment failure of patients on ARV first line in Kinshasa conducted in 3 treatment centers for AMO-Congo gave a rate of 17.6%.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Collaborative Research on Internal Medicine & Public Health.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Collaborative Research on Internal Medicine & Public Health
  • SubjectPublic Health & Epidemiology
  • BylineArticles whose byline prints “KAMANGU NTAMBWE ERICK”
  • BylineArticles whose byline prints “KAWILA MAFANDA EUPHRASIE”
  • BylineArticles whose byline prints “MUKUMBI HENRI”
  • BylineArticles whose byline prints “MVUMBI LELO GEORGES”